Drug
Sorbitol
Sorbitol is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
40%(2 trials)
Phase Distribution
Ph phase_2
2
40%
Ph phase_1
1
20%
Ph phase_4
2
40%
Phase Distribution
1
Early Stage
2
Mid Stage
2
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
2(40.0%)
Phase 4Post-market surveillance
2(40.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(5)
Detailed Status
Completed5
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 11 (20.0%)
Phase 22 (40.0%)
Phase 42 (40.0%)
Trials by Status
completed5100%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_2
Metabolic Cofactor Supplementation in Obese Patients With Non-Alcoholic Fatty Liver Disease
NCT04330326
completedphase_2
Metabolic Cofactor Supplementation in Alzheimer's Disease (AD) and Parkinson's Disease (PD) Patients
NCT04044131
completedphase_4
A Phase IV, Open Label, 4-period Cross-over Study to Investigate a Drug Interaction Between Lamivudine and Sorbitol Oral Solutions in Healthy Volunteers
NCT02634073
completedphase_1
Effect of Xylitol on Oral Microbiota in Children
NCT01528969
completedphase_4
Bifidobacterium Lactis BB12 and Xylitol Delivered With a Novel Slow-release Pacifier
NCT00638677
Clinical Trials (5)
Showing 5 of 5 trials
NCT04330326Phase 2
Metabolic Cofactor Supplementation in Obese Patients With Non-Alcoholic Fatty Liver Disease
NCT04044131Phase 2
Metabolic Cofactor Supplementation in Alzheimer's Disease (AD) and Parkinson's Disease (PD) Patients
NCT02634073Phase 4
A Phase IV, Open Label, 4-period Cross-over Study to Investigate a Drug Interaction Between Lamivudine and Sorbitol Oral Solutions in Healthy Volunteers
NCT01528969Phase 1
Effect of Xylitol on Oral Microbiota in Children
NCT00638677Phase 4
Bifidobacterium Lactis BB12 and Xylitol Delivered With a Novel Slow-release Pacifier
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5